In recent trading, Colgate-Palmolive Co. (Symbol: CL) shares have surpassed the average analyst 12-month target price of $81.18, currently priced at $81.43. This shift raises questions regarding potential analyst reactions, which could include downgrading the valuation or adjusting target prices upward. The Zacks coverage universe features a range of 11 analyst targets for CL, from a low of $71.00 to a high of $87.00, with a standard deviation of $4.308.
As of the latest data, there are three strong buy ratings, 11 hold ratings, and no sell or strong sell ratings for Colgate-Palmolive. The average analyst rating stands at 2.57 on a scale where 1 is a strong buy and 5 is a strong sell. Investors are encouraged to assess whether CL’s current valuation reflects a milestone toward higher targets or if it’s time to consider profit-taking.
